Tivicay
Dolutegravir tablets for HIV-1 infection. It blocks an enzyme the virus needs to copy itself into cells.
- Category
- HIV Management
- Active ingredient
- Dolutegravir
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg
Tivicay is the reference name. You receive a generic with the same active ingredient and strength.
Supply requirements for Tivicay depend on the medicine and destination. The fulfilment partner must confirm them before accepting an order.
Tivicay details
- Alternative names
- dolutegravir
- Therapeutic class
- Integrase Strand Transfer Inhibitor (INSTI)
- Pharmacological class
- Antiretroviral
- Contraindications
- concurrent dofetilide use; hypersensitivity to dolutegravir
- Minor side effects
- headache; insomnia; nausea
- Moderate side effects
- fatigue; diarrhoea; elevated blood lipids
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- ViiV Healthcare
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Antacids; Rifampin; Carbamazepine
- Age restrictions
- Approved for paediatric patients over four weeks and adults.
Serious side effects
hepatotoxicity, requires immediate medical attention; severe hypersensitivity reactions, requires immediate medical attention
Patient summary
Dolutegravir tablets for HIV-1 infection. It blocks an enzyme the virus needs to copy itself into cells.
Mechanism of action
Binds directly to active site of viral integrase, preventing host chromosome insertion of viral DNA.
Pregnancy and breastfeeding
Pregnancy: Avoid in first trimester unless benefits justify risks. Breastfeeding: Avoid.
What you will receive
Tivicay names the medicine you are looking for. What ships is a generic version of it.
- A generic containing Dolutegravir at the strength you pick.
- Which generic brand and maker ships depends on stock and destination.
- Check the active ingredient, strength, form, pack, seal, batch and expiry when it arrives.